4//SEC Filing
Mitchener Stephen 4
Accession 0000899243-21-021292
CIK 0001503802other
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 4:05 PM ET
Size
7.7 KB
Accession
0000899243-21-021292
Insider Transaction Report
Form 4
Mitchener Stephen
SVP, Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2021-05-30+1,500→ 3,000 total - Exercise/Conversion
Restricted Stock Units
2021-05-30−1,500→ 1,500 total→ Common Stock (1,500 underlying)
Footnotes (3)
- [F1]Restricted stock units ("RSUs") convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis.
- [F2]The reporting person has reported a prior award of 3,000 RSUs (described in footnote 3 below) in Table II of Form 4. The total reported in Column 5 includes 1,500 RSUs previously reported in Table II and 1,500 shares of common stock.
- [F3]On November 30, 2020, the reporting person was granted 3,000 RSUs, which vested as to 50% of the shares on May 30, 2021, with the remaining 50% vesting on November 30, 2021. 1,500 of the RSUs vested on May 30, 2021. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001774519
Filing Metadata
- Form type
- 4
- Filed
- May 31, 8:00 PM ET
- Accepted
- Jun 1, 4:05 PM ET
- Size
- 7.7 KB